Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released Oct 19, 2023, after the close
10-Q filed Oct 19, 2023, 19 days after period end · 0001493152-23-037702
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$2.39M | -$2.32M | -$863.12K | -$256.87K |
| EPS Diluted | -$0.19 | -$0.18 | -$0.07 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2023 · filed Oct 19, 2023 · 19 d after period end
4.8% from the close of Oct 19, 2023 to the close of Oct 23, 2023, the first after the release.